A U.S. court has issued a ruling that restricts abortion access nationwide by blocking the mailing of mifepristone. The decision impacts state policies, with the ruling stating that FDA actions allowing such abortions undermine bans and policies recognizing unborn children as legal persons from conception.

“Every abortion facilitated by FDA's action cancels Louisiana's ban on medical abortions and undermines its policy that every unborn child is a human being from the moment of conception and is, therefore, a legal person,” the ruling states